COMP <GO>
ABT vs AZN // RSI-14 & 200D SMA MOMENTUM
Abbott Laboratories (NYSE) VS. AstraZeneca PLC (NYSE) • 15-METRIC TALLY: ABT 9
— AZN 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: AZN
LAST: $104.57 (+1.88%) • MKT CAP: $180.95B
rsi-technicals
54.2
LAST: $174.40 (+2.89%) • MKT CAP: $270.45B
rsi-technicals
56.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABT VS. AZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABT | AZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 9.90% | +2.00 | ABT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.4x | 21.0x | -2.60 | ABT | /valuation <GO> |
| Free Cash Flow Yield | 4.09% | 2.21% | +1.88 | ABT | /fcf-yield <GO> |
| Operating Margin | 18.20% | 13.90% | +4.30 | ABT | /operating-margins <GO> |
| Net Profit Margin | 14.70% | 10.90% | +3.80 | ABT | /net-margins <GO> |
| Revenue Growth (YoY) | 5.70% | 22.00% | -16.30 | AZN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.27% | 0.00% | +2.27 | ABT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.36 | 3.74 | +0.62 | ABT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 54.2 | 56.8 | -2.60 | AZN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.91 | +0.08 | ABT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 25.8x | 27.6x | -1.80 | ABT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $180.95B | $270.45B | -$89.50B | AZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABT REV | AZN REV | ABT GROSS % | AZN GROSS % | ABT FCF | AZN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.33B | — | 56.4% | — | $7.39B | — |
| FY 2024 | $41.95B | — | 55.4% | — | $6.35B | — |
| FY 2023 | $40.11B | — | — | — | $5.46B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABT // BETA 0.99
AZN // BETA 0.91